Age, Biography and Wiki
Connor Glass was born on 1992 in San Antonio, Texas, is an American physician and researcher (born 1992). Discover Connor Glass's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 32 years old?
| Popular As |
N/A |
| Occupation |
Chief Executive Officer of Phantom Neuro |
| Age |
32 years old |
| Zodiac Sign |
N/A |
| Born |
1992 |
| Birthday |
|
| Birthplace |
San Antonio, Texas |
| Nationality |
|
We recommend you to check the complete list of Famous People born on .
He is a member of famous Physician with the age 32 years old group.
Connor Glass Height, Weight & Measurements
At 32 years old, Connor Glass height not available right now. We will update Connor Glass's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Connor Glass Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Connor Glass worth at the age of 32 years old? Connor Glass’s income source is mostly from being a successful Physician. He is from . We have estimated Connor Glass's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
Physician |
Connor Glass Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
Connor Glass is an American physician, entrepreneur, and researcher specializing in neurotechnology and prosthetics.
He is the founder and CEO of Phantom Neuro, a company focused on developing advanced control systems for robotic prosthetics and exoskeletons.
Connor Glass was born in San Antonio, Texas, and moved to Oklahoma when he was three years old.
His interest in surgery began at a young age, and he started shadowing doctors at thirteen.
He pursued a Bachelor of Science in biology with a minor in Chemistry at Texas Christian University from 2011 to 2015, where he was also part of the Reserve Officers' Training Corps.
During his undergraduate studies, he earned an EMT-Basic degree with a specialization in Emergency Medical Technology from Tarrant County College in 2012.
He obtained his medical degree from the University of Oklahoma College of Medicine (2016–2021) and completed a research fellowship in Plastic Surgery and Neuroengineering at Johns Hopkins University School of Medicine.
In 2017, Glass founded Medic, a mobile platform designed to increase patient involvement in medical experiences.
Medic is an app-based platform, and Dr. Glass served as CEO until 2020.
During his fellowship at Johns Hopkins, Glass explored the intersection between robotics and prosthetics, leading to the launch of Phantom Neuro in 2022.
The company's product, patented through Johns Hopkins Technology Ventures, is a minimally-invasive implantable sensor that uses Internet of Things (IoT) Wi-Fi technology to provide lifelike control of prosthetics and exoskeletons.
Phantom Neuro's purpose is to merge orthopedics and robotics.
The product was created to induce life-like of prosthetics and exoskeletons.
It is a minimally-invasive implantable sensor that utilizes Internet of Things Wi-Fi technology to ensure optimal connections and control.
In 2022, Phantom Neuro received $3.2 million in funding for preclinical studies, totaling $9.5 million later that year.
In 2023, the company announced successful trials in pigs and plans to move on to human trials.
